Supply Chain/Technology

Latest Issue of OR Manager
February 2025
Home Supply Chain/Technology

Scentech Medical to start trial for COVID-19 breath test

Editor's Note Israel-based Scentech Medical and Meir Medical Center will start a trial of Scentech’s breath technology, which is designed to detect COVID-19 before it becomes symptomatic, the April 22 Times of Israel reports. The breath test technology—similar to breathalyzers used on suspected drunk drivers—is a mix of software and…

Read More

By: Judy Mathias
April 23, 2020
Share

Developing a COVID-19 Recovery Plan for surgical services

When the coronavirus pandemic begins to subside, hospital leaders will be sorting out the repercussions and trying to resume normal operations. The main impact on ORs has been the widespread cancellation of non-essential procedures. Case cancellations in March and April have reduced elective procedure volumes as much as 90%. Most…

Read More

By: OR Manager
April 23, 2020
Share

IUSS sterilizes N95 masks without damaging masks

Editor's Note In this study from the Houston Methodist Research Institute, immediate-use steam sterilization (IUSS) using a Steris Amsco Evolution HC1500 PreVac Steam Sterilizer autoclave was performed on N95 masks. Masks were wrapped in paper-plastic sterilization peel pouches (Medical Action Industries 8” role, Ref 422R). A chemical indicator and biological…

Read More

By: Judy Mathias
April 22, 2020
Share

ACS releases new guidance to help healthcare facilities prepare for resuming surgery

Editor' Note The American College of Surgeons (ACS) on April 17 released a new document, “Local Resumption of Elective Surgery Guidance,” to help healthcare facilities prepare to resume elective surgery once COVID-19 has peaked in their area. The document includes four categories: COVID Awareness—addresses the community’s COVID-19 numbers, including prevalence,…

Read More

By: Judy Mathias
April 20, 2020
Share

Sponsored Message

FDA updates actions taken in response to COVID-19

Editor's Note Among the actions announced April 15 by the Food & Drug Administration (FDA) in response to the COVID-19 pandemic are: Issuance of two new emergency use authorizations (EUAs) for serology tests, to detect for presence of coronavirus antibodies, to Ortho-Clinical Diagnostics, Inc, and Chembio Diagnostic systems, Inc. Issuance…

Read More

By: Judy Mathias
April 16, 2020
Share

Australian researchers test lung ventilation of two patients with one ventilator

Editor's Note In this experimental study from Australia, researchers investigate the effect of ventilator splitting on system variables (ie, inspiratory pressure, flow, and volume) and the possibility of different ventilation targets for each limb. Connecting two patients to the same ventilator presents many challenges: ventilation requirements are different for different…

Read More

By: Judy Mathias
April 14, 2020
Share

Sponsored Message

Safe Flight Instrument Corporation creates ventilator splitter

Editor's Note Safe Flight Instrument Corporation (White Plains, New York), a company that develops aircraft safety and performance technology, has developed the Quad/Vent Splitter that allows four patients to use one ventilator simultaneously, the April 13 Aviation International News Online reports. Using 3-D printing, the device has four independent ports…

Read More

By: Judy Mathias
April 14, 2020
Share

FDA issues COVID-19 update

Editor's Note The Food & Drug Administration (FDA) on April 7 issued an update on actions the agency has taken in its ongoing response to the COVID-19 pandemic. The actions include: a guidance for remote ophthalmic assessment and monitoring devices to facilitate patient care while reducing patient and healthcare provider…

Read More

By: Judy Mathias
April 8, 2020
Share

AI used to screen existing drugs, compounds for use against COVID-19

Editor's Note Exscientia (Oxford, UK) has announced a joint initiative with Diamond Light Source (Oxforshire, UK) and Calibr (La Jolla, California), a division of  Scripps Research, to use its artificial intelligence (AI) drug discovery platform to identify compounds that could become viable drugs for treatment of COVID-19, the April 2…

Read More

By: Judy Mathias
April 7, 2020
Share

Case series of critically ill COVID-19 patients in Seattle

Editor's Note During the first 3 weeks of the COVID-19 outbreak in the Seattle area, the most common reasons for ICU admission were hypoxemic respiratory failure leading to mechanical ventilation and/or hypotension requiring vasopressor treatment, and mortality was high in these critically ill patients, this study finds. In this analysis…

Read More

By: Judy Mathias
April 2, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat